The men shared their common struggle to get prostate-specific antigen testing: ‘I know more than my GPs about my high risk of prostate cancer’, and asked, ‘How long will it take for this research to change our care?’ Additional research priorities included evaluation of a prostate cancer screening programme for high-risk populations and including black men. The gene discussed is KLK3; the disease is prostate cancer.